Clinical Trial Update: Effects of Prescription Omega-3 on LDL-C in Primary Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating prescription omega-3's effect on LDL-C in primary hypercholesterolemia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Prescription Omega-3 (omega-3 fatty acids)

Snippet

Sponsor: Provident Clinical Research | Conditions: Primary Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2024-05-08